Cargando…

Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice

BACKGROUND AND AIM: The major conjugated linoleic acid (CLA) isomers have anticancer effect, especially breast cancer cells, inhibits cell growth and induces cell death. Also, CLA has several health benefits in vivo, including antiatherogenesis, antiobesity, and modulation of immune function. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Gawad, Abdelrahman M. Abd, El-Hassan, Diea G. Abo, Aboul-Enein, Ahmed M., Abdelgayed, Sherein S., Aly, Salwa A., Esmat, Gamal, Mostafa, Amr A., Bakr, Mohamed H., Ali, Rida A., Ayoub, Mahmoud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076465/
https://www.ncbi.nlm.nih.gov/pubmed/33935416
http://dx.doi.org/10.14202/vetworld.2021.696-708
_version_ 1783684685881147392
author El-Gawad, Abdelrahman M. Abd
El-Hassan, Diea G. Abo
Aboul-Enein, Ahmed M.
Abdelgayed, Sherein S.
Aly, Salwa A.
Esmat, Gamal
Mostafa, Amr A.
Bakr, Mohamed H.
Ali, Rida A.
Ayoub, Mahmoud A.
author_facet El-Gawad, Abdelrahman M. Abd
El-Hassan, Diea G. Abo
Aboul-Enein, Ahmed M.
Abdelgayed, Sherein S.
Aly, Salwa A.
Esmat, Gamal
Mostafa, Amr A.
Bakr, Mohamed H.
Ali, Rida A.
Ayoub, Mahmoud A.
author_sort El-Gawad, Abdelrahman M. Abd
collection PubMed
description BACKGROUND AND AIM: The major conjugated linoleic acid (CLA) isomers have anticancer effect, especially breast cancer cells, inhibits cell growth and induces cell death. Also, CLA has several health benefits in vivo, including antiatherogenesis, antiobesity, and modulation of immune function. The present study aimed to assess the safety and anticancer effects of milk fat CLA against in vivo Ehrlich ascites carcinoma (EAC) in female Swiss albino mice. This was based on acute toxicity study, detection of the tumor growth, life span of EAC bearing hosts, and simultaneous alterations in the hematological, biochemical, and histopathological profiles. MATERIALS AND METHODS: One hundred and fifty adult female mice were equally divided into five groups. Groups (1-2) were normal controls, and Groups (3-5) were tumor transplanted mice (TTM) inoculated intraperitoneally with EAC cells (2×10(6)/0.2 mL). Group (3) was (TTM positive control). Group (4) TTM fed orally on balanced diet supplemented with milk fat CLA (40 mg CLA/kg body weight). Group (5) TTM fed orally on balanced diet supplemented with the same level of CLA 28 days before tumor cells inoculation. Blood samples and specimens from liver and kidney were collected from each group. The effect of milk fat CLA on the growth of tumor, life span of TTM, and simultaneous alterations in the hematological, biochemical, and histopathological profiles were examined. RESULTS: For CLA treated TTM, significant decrease in tumor weight, ascetic volume, viable Ehrlich cells accompanied with increase in life span were observed. Hematological and biochemical profiles reverted to more or less normal levels and histopathology showed minimal effects. CONCLUSION: The present study proved the safety and anticancer efficiency of milk fat CLA and provides a scientific basis for its medicinal use as anticancer attributable to the additive or synergistic effects of its isomers.
format Online
Article
Text
id pubmed-8076465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Veterinary World
record_format MEDLINE/PubMed
spelling pubmed-80764652021-04-30 Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice El-Gawad, Abdelrahman M. Abd El-Hassan, Diea G. Abo Aboul-Enein, Ahmed M. Abdelgayed, Sherein S. Aly, Salwa A. Esmat, Gamal Mostafa, Amr A. Bakr, Mohamed H. Ali, Rida A. Ayoub, Mahmoud A. Vet World Research Article BACKGROUND AND AIM: The major conjugated linoleic acid (CLA) isomers have anticancer effect, especially breast cancer cells, inhibits cell growth and induces cell death. Also, CLA has several health benefits in vivo, including antiatherogenesis, antiobesity, and modulation of immune function. The present study aimed to assess the safety and anticancer effects of milk fat CLA against in vivo Ehrlich ascites carcinoma (EAC) in female Swiss albino mice. This was based on acute toxicity study, detection of the tumor growth, life span of EAC bearing hosts, and simultaneous alterations in the hematological, biochemical, and histopathological profiles. MATERIALS AND METHODS: One hundred and fifty adult female mice were equally divided into five groups. Groups (1-2) were normal controls, and Groups (3-5) were tumor transplanted mice (TTM) inoculated intraperitoneally with EAC cells (2×10(6)/0.2 mL). Group (3) was (TTM positive control). Group (4) TTM fed orally on balanced diet supplemented with milk fat CLA (40 mg CLA/kg body weight). Group (5) TTM fed orally on balanced diet supplemented with the same level of CLA 28 days before tumor cells inoculation. Blood samples and specimens from liver and kidney were collected from each group. The effect of milk fat CLA on the growth of tumor, life span of TTM, and simultaneous alterations in the hematological, biochemical, and histopathological profiles were examined. RESULTS: For CLA treated TTM, significant decrease in tumor weight, ascetic volume, viable Ehrlich cells accompanied with increase in life span were observed. Hematological and biochemical profiles reverted to more or less normal levels and histopathology showed minimal effects. CONCLUSION: The present study proved the safety and anticancer efficiency of milk fat CLA and provides a scientific basis for its medicinal use as anticancer attributable to the additive or synergistic effects of its isomers. Veterinary World 2021-03 2021-03-20 /pmc/articles/PMC8076465/ /pubmed/33935416 http://dx.doi.org/10.14202/vetworld.2021.696-708 Text en Copyright: © Abd El-Gawad, et al. https://creativecommons.org/licenses/by/4.0/Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
El-Gawad, Abdelrahman M. Abd
El-Hassan, Diea G. Abo
Aboul-Enein, Ahmed M.
Abdelgayed, Sherein S.
Aly, Salwa A.
Esmat, Gamal
Mostafa, Amr A.
Bakr, Mohamed H.
Ali, Rida A.
Ayoub, Mahmoud A.
Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice
title Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice
title_full Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice
title_fullStr Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice
title_full_unstemmed Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice
title_short Anticancer activity of milk fat rich in conjugated linoleic acid against Ehrlich ascites carcinoma cells in female Swiss albino mice
title_sort anticancer activity of milk fat rich in conjugated linoleic acid against ehrlich ascites carcinoma cells in female swiss albino mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076465/
https://www.ncbi.nlm.nih.gov/pubmed/33935416
http://dx.doi.org/10.14202/vetworld.2021.696-708
work_keys_str_mv AT elgawadabdelrahmanmabd anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT elhassandieagabo anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT abouleneinahmedm anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT abdelgayedshereins anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT alysalwaa anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT esmatgamal anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT mostafaamra anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT bakrmohamedh anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT aliridaa anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice
AT ayoubmahmouda anticanceractivityofmilkfatrichinconjugatedlinoleicacidagainstehrlichascitescarcinomacellsinfemaleswissalbinomice